It also appears that the cytotoxic effects of chemotherapy, which can damage DNA and lead to aberrations in genes related to DNA repair mechanisms, such as TP53 and ATM, may contribute to the development of secondary malignancies in CLL patients. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.